NBP

NASDAQ open

NovaBridge Biosciences

0.85 USD
▼-0.03-3.41%
盘后 0.95 0.00%
2026-11-20
市值
$96.28M
市盈率
—
EPS
-1.04
股息率
—
52 周区间
0.75 – 5.19
成交量
708.55K
Beta
1.72
目标价
8.67
52W 低 0.7552W 高 5.19
价格走势

公司简介

NovaBridge Biosciences, a biotechnology company, engages in the research and development of immuno-oncology agents for the treatment of cancer in the United States. The company operates through two segments, Oncology and Ophthalmology. Its product pipeline comprises givastomig, a potential CLDN18.2 bispecific antibody, which is in phase 2 clinical trial combination with nivolumab and chemotherapy for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies; Phase 1b clinical trial in combination with nivolumab a...